MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia

Journal of Pediatric Gastroenterology and Nutrition

Volumn 54, Issue 2, 2012, Pages 186-192

  Hand, Nicholas J ^a   Horner, Amber M ^a   Master, Zankhana R ^a   Boateng, Latasha A ^a   Leguen, Claire ^a   Uvaydova, Marina ^a   Friedman, Joshua R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

biliary atresia; cholestasis; inflammation; microRNA

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; INTERLEUKIN 1; MICRORNA; MIR 29A; MIR 29B1; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT ATRESIA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RNA ANALYSIS; UPREGULATION;

ANIMALS; BILIARY ATRESIA; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKERS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN; LIVER; MICE; MICE, INBRED BALB C; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGORIBONUCLEOTIDES, ANTISENSE; TRANSCRIPTOME;

MUS;

EID: 84856258714     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318244148b     Document Type: Article

References (53)

1. Bezerra JA. Potential etiologies of biliary atresia. Pediatr Transplant 2005;9:646-51. (Pubitemid 41413507)
2. Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet 2009;374:1704-13.
3. Schreiber RA, Kleinman RE. Biliary atresia. J Pediatr Gastroenterol Nutr 2002;35 (suppl 1):S11-6. (Pubitemid 34774373)
4. Mieli-Vergani G, Vergani D. Biliary atresia. Semin Immunopathol 2009;31:371-81.
5. Sokol RJ, Shepherd RW, Superina R, et al. Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology 2007;46:566-81. (Pubitemid 47344793)
6. Riepenhoff-Talty M, Schaekel K, Clark HF, et al. Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res 1993;33:394-9. (Pubitemid 23095773)
7. Shivakumar P, Campbell KM, Sabla GE, et al. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest 2004;114:322-9. (Pubitemid 39071604)
8. Shivakumar P, Sabla G, Mohanty S, et al. Effector role of neonatal hepatic CD8 lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia. Gastroenterology 2007;133:268-77. (Pubitemid 47031130)
9. Carvalho E, Liu C, Shivakumar P, et al. Analysis of the biliary transcriptome in experimental biliary atresia. Gastroenterology 2005;129:713-7. (Pubitemid 41096655)
10. Leonhardt J, Stanulla M, von Wasielewski R, et al. Gene expression profile of the infective murine model for biliary atresia. Pediatr Surg Int 2006;22:84-9. (Pubitemid 43052204)
11. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21. (Pubitemid 32397092)
12. Hand NJ, Master ZR, Eauclaire SF, et al. The microRNA-30 family is required for vertebrate hepatobiliary development. Gastroenterology 2009;136:1081-90.
13. Wu Z, Irizarry R, Gentleman R, et al. A model-based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc 2004;99:909-17. (Pubitemid 39665934)
14. Chivukula RR, Mendell JT. Circular reasoning: microRNAs and cellcycle control. Trends Biochem Sci 2008;33:474-81.
15. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
16. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009;37:1-13.
17. Liu P, Jenkins NA, Copeland NG. A highly efficient recombineeringbased method for generating conditional knockout mutations. Genome Res 2003;13:476-84. (Pubitemid 36395405)
18. Merkerova M, Vasikova A, Belickova M, et al. MicroRNA expression profiles in umbilical cord blood cell lineages. Stem Cells Dev 2010;19:17-26.
19. Fazi F, Rosa A, Fatica A, et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005;123:819-31. (Pubitemid 41721029)
20. Bandyopadhyay S, Friedman RC, Marquez RT, et al. Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. J Infect Dis 2011;203:1753-62.
21. Cushing L, Kuang PP, Qian J, et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 2011;45:287-94.
22. Roderburg C, Urban GW, Bettermann K, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011;53:209-18.
23. Xiong Y, Fang JH, Yun JP, et al. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 2010;51:836-45.
24. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21. (Pubitemid 32397092)
25. Fabbri M, Garzon R, Cimmino A, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 2007;104:15805-10. (Pubitemid 350035380)
26. Boominathan L. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network. Cancer Metastasis Rev 2010;29:613-39.
27. Mott JL, Kurita S, Cazanave SC, et al. Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB. J Cell Biochem 2010;110:1155-64.
28. Onori P, Alvaro D, Floreani AR, et al. Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis. J Histochem Cytochem 2007;55:327-34. (Pubitemid 46481940)
29. Jensen LE, Muzio M, Mantovani A, et al. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein. J Immunol 2000;164:5277-86. (Pubitemid 30305206)
30. Zahm AM, Thayu M, Hand NJ, et al. Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2011;53:26-33.
31. Meenhuis A, van Veelen PA, de Looper H, et al. MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1-regulated pathways in mice. Blood 2011;118:916-25.
32. Li G, Luna C, Qiu J, et al. Alterations in microRNA expression in stressinduced cellular senescence. Mech Ageing Dev 2009;130:731-41.
33. Merkerova M, Belickova M, Bruchova H. Differential expression of microRNAs in hematopoietic cell lineages. Eur J Haematol 2008; 81:304-10.
34. Kim T, Veronese A, Pichiorri F, et al. p53 regulates epithelialmesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 2011;208:875-83.
35. McKenna LB, Schug J, Vourekas A, et al. MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 2010;139:1654-64.64 e1.
36. Roderburg C, Urban GW, Bettermann K, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011;53:209-18.
37. Rogler CE, Levoci L, Ader T, et al. MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology 2009;50:575-84.
38. Sekiya Y, Ogawa T, Yoshizato K, et al. Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun 2011;412:74-9.
39. Song G, Sharma AD, Roll GR, et al. MicroRNAs control hepatocyte proliferation during liver regeneration. Hepatology 2010;51:1735-43.
40. Lou Y, Yang X, Wang F, et al. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int J Mol Med 2010;26:819-27.
41. Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007;133:647-58. (Pubitemid 47187346)
42. Jorgensen S, Baker A, Moller S, et al. Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 2010;52:375-81.
43. Harris TA, Yamakuchi M, Ferlito M, et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A 2008;105:1516-21. (Pubitemid 351346546)
44. Wang K, Zhang S,Weber J, et al. Export of microRNAs and microRNAprotective protein by mammalian cells. Nucleic Acids Res 2010;38: 7248-59.
45. Matthews RP, Eauclaire SF, Mugnier M, et al. DNA hypomethylation causes bile duct defects in zebrafish and is a distinguishing feature of infantile biliary atresia. Hepatology 2011;53:905-14.
46. Kwiecinski M, Noetel A, Elfimova N, et al. Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction. PLoS One 2011;6:e24568.
47. Sekiya Y, Ogawa T, Yoshizato K, et al. Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun 2011;412:74-9.
48. Braconi C, Kogure T, Valeri N, et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 2011;30:4750-6.
49. Onori P, Alvaro D, Floreani AR, et al. Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis. J Histochem Cytochem 2007;55:327-34.
50. Gatto M, Drudi-Metalli V, Torrice A, et al. Insulin-like growth factor-1 isoforms in rat hepatocytes and cholangiocytes and their involvement in protection against cholestatic injury. Lab Invest 2008;88:986-94.
51. Jensen LE, Whitehead AS. Expression of alternatively spliced interleukin-1 receptor accessory protein mRNAs is differentially regulated during inflammation and apoptosis. Cell Signal 2003;15:793-802. (Pubitemid 36627868)
52. Jensen LE, Muzio M, Mantovani A, et al. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein. J Immunol 2000;164:5277-86. (Pubitemid 30305206)
53. Jensen LE, Whitehead AS. The 30 untranslated region of the membranebound IL-1R accessory protein mRNA confers tissue-specific destabilization. J Immunol 2004;173:6248-58. (Pubitemid 39487783)